Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma.

Hui-Hsin KoShih-Jung ChengJang-Jaer LeeHsin-Ming ChenMark Yen-Ping KuoShih-Jung Cheng

Published in: Head & neck (2017)

AKR1B10 overexpression is an independent poor prognostic biomarker for OSCC. AKR1B10 inhibitors may be promising in clinical trials against OSCC. © 2017 Wiley Periodicals, Inc. Head Neck 39: 1327-1332, 2017.

Keyphrases

poor prognosis
long non coding rna
clinical trial
endothelial cells
cell proliferation
induced pluripotent stem cells
transcription factor
pluripotent stem cells
randomized controlled trial
phase ii